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Abstract
Introduction: Osteoarthritis (OA) is a multifactorial disease, and recent studies have suggested that cell cycle–related
proteins play a role in OA pathology. p21 was initially identified as a potent inhibitor of cell cycle progression. However,
it has been proposed that p21 is a regulator of transcription factor activity. In this study, we evaluated the role of p21
in response to biomechanical stress.
Methods: Human chondrocytes were treated with p21-specific small interfering RNA (siRNA), and cyclic tensile strain
was introduced in the presence or absence of a signal transducer and activator of transcription 3 (STAT3)-specific
inhibitor. Further, we developed an in vivo OA model in a p21-knockout background for in vivo experiments.
Results: The expression of matrix metalloproteinase (MMP13) mRNA increased in response to cyclic tensile strain
following transfection with p21 siRNA, whereas the expression of aggrecan was decreased. Phospho-STAT3 and
MMP-13 protein levels increased following downregulation of p21, and this was reversed by treatment with a STAT3
inhibitor. p21-deficient mice were susceptible to OA, and this was associated with increased STAT3 phosphorylation,
elevated MMP-13 expression, and elevation of synovial inflammation. The expression of p21 mRNA was decreased and
phosphorylation of STAT3 was elevated in human OA chondrocytes.
Conclusions: The lack of p21 has catabolic effects by regulation of aggrecan and MMP-13 expression through STAT3
phosphorylation in the cartilage tissue. p21 may function as a regulator of transcriptional factors other than the
inhibitor of cell cycle progression in the cartilage tissue. Thus, the regulation of p21 may be a therapeutic strategy for
the treatment of OA.
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Introduction
The development of osteoarthritis (OA) is related to
genetic factors, biomechanical stress, and biological fac-
tors within the joints [1–3]. Previous reports showed
that mechanical stress can alter the matrix synthetic
activity [4]. It has also been found that excessive mech-
anical stress may alter chondrocyte metabolism and
reduce the amount of extracellular matrix (ECM) [5, 6].
Type II collagen and aggrecan (ACAN) are the main
components of the articular cartilage ECM. In the OA
cartilage environment, the loss of type II collagen and
ACAN is due to decreased protein synthesis by chon-
drocytes and activation of ECM-degrading enzymes such
as matrix metalloproteinases (MMPs) and a disintegrin
and metalloproteinase with thrombospondin motifs
(ADAMTS) [7]. The loss of ACAN through the activity
of aggrecanase enzymes is a key event in early OA, and
ADAMTS4 and ADAMTS5 are the major cartilage
aggrecanases in humans [8]. MMPs, especially MMP-13,
are critical enzymes involved in the degeneration of
articular cartilage in OA [9].
The cyclin-dependent kinase inhibitor p21 was initially
identified as a potent inhibitor of cell cycle progression
[10–13]. Knockout of p21 induced a regenerative
response in an appendage of an otherwise nonregenerating
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mouse strain [14]. Subsequent studies further identified
that p21 has an important role in controlling cytostasis
and cell death [15]. p21 transcription is activated by p53,
and p21 is part of a negative feedback mechanism that
controls p53 activity during apoptosis [16]. It is also an
important mediator of inflammation and vascular smooth
muscle cell proliferation [17]. Recently, p21 has been
shown to regulate the activity of nuclear factor κB, c-Myc,
CCAAT-enhancer-binding proteins, E2F, and signal trans-
ducer and activator of transcription 3 (STAT3) transcrip-
tion factors [18–21]. p21 regulates cell proliferation and
inflammation after arterial injury in local vascular cells
[22]. Furthermore, downregulation of p21 increases the
expression of stromal cell–derived factor 1 (SDF-1) via the
STAT3 pathway [23]. A previous report showed that
SDF-1 induced MMP-13 expression in chondrocytes [24].
Given these links between p21 and chondrocytes, a pre-
vious report showed that articular chondrocytes expressed
high levels of p21 with positive senescent cells by
senescence-associated β-galactosidase staining [25]. An-
other study showed that interleukin (IL)-1β increased
proliferation and caused a G1-to-S phase shift in chondro-
cytes, accompanied by a reduction of p21, and reduction
of p21 caused delayed cell differentiation, manifested by
decreases in proteoglycan synthesis, mineralization, alka-
line phosphatase activity, and matrix proteins [26].
We initiated the present study to investigate the func-
tion of p21 in cartilage homeostasis. Specifically, we
focused on the relationship between p21 and STAT3 in
chondrocyte and joint biology in response to mechanical
stress both in vitro and in vivo.
Methods
Preparation of human cartilage
Cartilage tissues were obtained during total hip joint re-
placement surgery from 11 patients with OA. Diagnosis
of OA was based on clinical, laboratory, and radio-
graphic evaluations. Normal cartilage tissues were ob-
tained during surgery for femoral neck fractures from
eight patients with no history of joint disease and with
macroscopically normal cartilage. All the samples were ob-
tained in accordance with the World Medical Association
Declaration of Helsinki Ethical Principles for Medical
Research Involving Human Subjects. The study protocol
was approved by Kobe University Graduate school of
Medicine Ethics Committee, and all patients gave their
informed consent.
Cell culture
Primary chondrocytes were isolated and cultured from
the cartilage tissues. Tissues were minced and incubated
with trypsin (0.5 mg/ml; Sigma-Aldrich, St. Louis, MO,
USA) for 15 minutes at 37 °C, after which the cartilage
was treated with Dulbecco’s modified Eagle’s medium
(DMEM; Gibco/Life Technologies, Grand Island, NY, USA)
containing 0.2 % collagenase (Sigma-Aldrich) at 37 °C for
15 h. Dissociated cells were cultured in DMEM supple-
mented with 10 % fetal bovine serum (BioWhittaker FBS;
Lonza, Walkersville, MD, USA) and 100 U/ml penicillin-
streptomycin. After overnight culture, nonadherent cells
were removed and adherent cells were further incubated
on a 6-well plate in fresh medium (3 × 105 cells/well). All
experiments were conducted using first-passage cells. To
characterize the chondrocytes, we confirmed that the type
II collagen showed higher expression in the normal hu-
man hip chondrocytes than in the OA knee chondrocytes
and that type X collagen showed higher expression in the
OA chondrocytes than in the normal chondrocytes.
Cell culture and exposure to cyclic tensile strain
Normal human knee chondrocytes (NHAC-kn; Cambrex,
Charles City, IA, USA) were cultured in a humidified at-
mosphere of 5 % CO2 and 95 % air at 37 °C in a BulletKit
(Cambrex). NHAC-kn were derived from a single-donor
knee articular cartilage and used as an established normal
chondrocyte cell line [27, 28]. To characterize the chon-
drocytes, we confirmed that NHAC-kn expressed type II
collagen and sulfated proteoglycans, but not type X
collagen, before use.
Before we performed the experiments, cells were
grown to a subconfluent state (3 × 105 cells/well) in a
6-well plate and were then plated onto a silicon chamber
coated with fibronectin (Sigma-Aldrich) at a density of
3 × 105 cells/well in DMEM/F-12 supplemented with 10 %
FBS and 100 U/ml penicillin-streptomycin. Cyclic tensile
strain experiments were performed using an ST-140 cyclic
tensile strain system (STREX, Osaka, Japan). Cyclic tensile
strain was enforced at 3 %, 5 %, 8 %, and 10 % elongation
for 3 h (0.5 Hz) according to previous studies [23, 29, 30].
We used 5 % tensile strain as normal joint loading
and 10 % tensile strain as excessive loading to investi-
gate the relationship between mechanical stress and
cartilage metabolism.
Small interfering RNA transfection
Lipofectamine 2000 reagent was used to transfect p21
small interfering RNA (siRNA) and nonspecific siRNA
control into normal human knee chondrocyte mono-
layers according to the recommendations of the manu-
facturer (Life Technologies, Carlsbad, CA, USA). Briefly,
1 day before transfection, cells were plated in a 6-well
plate in growth medium without antibiotics to attain
30–50 % confluence at the time of transfection. Subse-
quently, 100 pmol of siRNA and Lipofectamine 2000
complexes were prepared and added to each well. After
12 h of transfection, the complexes were removed, and
fresh medium containing 10 % FBS was added. After
an additional 12 h, the cells were replaced onto a
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silicone chamber coated with fibronectin at a density
of 3 × 105 cells/well, and cyclic tensile strain was
applied.
Quantitative reverse transcription polymerase chain
reaction analysis
Chondrocytes were cultured in 6-well plates with various
stimulations, and RNA was extracted using a QIAshredder
and RNeasy Mini Kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s protocol. Briefly, 1 μg of total
RNA was reverse-transcribed to first-strand cDNA with
1.25 μM oligo(dT) primer in 40 μl of polymerase chain re-
action (PCR) buffer II containing 2.5 mM MgC12, 0.5 mM
deoxyribonucleotide triphosphate mix, 0.5 U of RNase
inhibitor, and 1.25 U of murine leukemia virus reverse
transcriptase (PerkinElmer/Applied Biosystems, Foster
City, CA, USA) at 42 °C for 60 minutes.
The relative expression levels of mRNA encoding
human p21, collagen, type II, alpha 1 (COL2A1), ACAN,
MMP3, MMP13, ADAMTS4, and ADAMTS5 were ana-
lyzed by SYBR Green real-time PCR using an ABI Prism
7700 sequence detection system (Applied Biosystems).
The relative expression of the genes of interest was nor-
malized against the GAPDH housekeeping gene by using
the comparative cycle threshold (Ct) method. The differ-
ence between the mean Ct values of the gene of interest
and the housekeeping gene is denoted as ΔCt, and the
difference between ΔCt and the Ct value of the calibrator
sample is denoted as ΔΔCt. The log2 (ΔΔCt) value gives
the relative level of gene expression. The primer se-
quence for detection of human p21, COL2A1, ACAN,
MMP3, MMP13, ADAMTS4, and ADAMTS5 are de-
scribed in the Additional file 1.
Western blot analysis
Chondrocytes were washed three times with phosphate-
buffered saline and lysed in a hypotonic lysis buffer
(25 mM Tris, 1 % Nonidet P-40, 150 mM NaCl, 1.5 mM
ethylene glycol tetraacetic acid) supplemented with a pro-
tease and phosphatase inhibitor mix (Roche Diagnostics,
Basel, Switzerland) on ice for 20 minutes [31]. The lysates
were centrifuged at 15,000 rpm for 20 minutes to remove
cellular debris, and the supernatants were collected.
Cytoplasmic proteins were quantified by using the
Bradford method with a protein assay reagent (Bio-Rad
Laboratories, Hercules, CA, USA) and diluted to an equal
concentration with the hypotonic buffer. The expression
of p21 protein was detected using rabbit anti-p21 poly-
clonal antibody (Ab) (Cell Signaling Technology, Danvers,
MA, USA). The expression levels of phosphorylated
STAT3 (phospho-STAT3 or p-STAT3) and STAT3 were
detected using rabbit anti-phospho-STAT3 and anti-
STAT3 Ab (Cell Signaling Technology).
Horseradish peroxidase (HRP)-conjugated goat anti-
rabbit immunoglobulin G (IgG) Ab (GE Healthcare
Bio-Sciences, Piscataway, NJ, USA) or HRP-conjugated
rabbit anti-mouse IgG Ab (GE Healthcare Bio-Sciences)
was used as a secondary antibody, and the signals were
visualized using Amersham ECL Plus reagent (GE
Healthcare Life Sciences, Little Chalfont, UK) with
the LAS-3000mini chemiluminescent image analyzer
(FUJIFILM Life Science, Tokyo, Japan). Actin was used as
a control to estimate protein loading on the gel.
Generation of homozygous mice
Homozygous B6.129S6(Cg)-Cdkn1atm1Led/J mice were
obtained from The Jackson Laboratory (Bar Harbor, ME,
USA). We backcrossed the mice against a C57BL/6
background and studied male mice at 10 weeks of age.
All the mice used in this study were backcrossed over 20
generations. p21+/+ littermates were used as wild-type
controls. Genotyping was performed by PCR amplifica-
tion of mouse-tail DNA by using allele-specific probes.
Each experimental group contained at least six mice.
In vivo mouse OA model
This study was carried out in strict accordance with the
recommendations contained in the Guide for the Care
and Use of Laboratory Animals of the National Institutes
of Health. All procedures were approved by the Animal
Studies Committee of Kobe University, Japan (permit
number P131104). Ten-week-old male p21−/− and p21+/+
mice were used in these experiments. Mice were
anesthetized using an intraperitoneal injection of ketamine
(100 mg/kg). Destabilization of the medial meniscus
(DMM) was induced in the right knee joint by transecting
the anterior attachment of the medial meniscotibial liga-
ment as described previously [32]. For the control, surgery
was performed on the right knee joints where the
ligaments were intact and termed sham. All mice were
subjected to weight-bearing following recovery from
anesthesia. The mice were sacrificed 8 weeks after DMM
or sham surgery, and their tissue was subjected to histo-
logical evaluation. Six mice were analyzed for each group:
p21+/+ sham, p21+/+ DMM, p21−/− sham, and p21−/−
DMM (total of 24 analyzed mice).
Histological evaluation for cartilage degeneration
Mouse knee joints were fixed with 4 % paraformaldehyde
for 24 h, decalcified with 14 % ethylenediaminetetraacetic
acid for 7 days, and embedded in paraffin. Coronal histo-
logical sections were taken through the joint at 80-μm in-
tervals and stained with Safranin O and Fast Green. OA
histopathology was evaluated by using the Osteoarthritis
Research Society International (OARSI) cartilage OA
histopathology scoring system [33]. Histological scores
were measured in four quadrants (medial femoral condyle,
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medial tibial plateau, lateral femoral condyle, and lateral
tibial plateau) of the knee joints at all sectioned levels
(eight sections per knee). A summed OA score was calcu-
lated from all four quadrants for all sections, which repre-
sented the changes across the whole joint.
Immunohistochemistry
Deparaffinized sections were digested with proteinase
(Dako, Glostrup, Denmark) for 10 minutes and treated
with 3 % hydrogen peroxide (Wako Pure Chemical
Industries, Osaka, Japan) to block endogenous peroxidase
activity. The sections were treated with a 1:100 dilution of
antiphosphorylated STAT3 (Cell Signaling Technology),
anti-MMP-13 (Abcam, Cambridge, UK), and anti-F4/80
(AbD Serotec, Kidlington, UK) antibodies at 4 °C over-
night and were subsequently treated with peroxidase-
labeled antirabbit Ig (Histofine Simple Stain MAX PO;
Nichirei Bioscience, Tokyo, Japan) at room temperature
for 30 minutes. The signal was developed as a brown
reaction product by using the peroxidase substrate
3,3′-diaminobenzidine (Histofine Simple Stain DAB
Solution; Nichirei Bioscience), and the sections were
examined microscopically. Methyl green stain was used as
a counterstain. One sagittal section from the center of the
most severe OA lesion in each tibial plateau was scored.
The number of stained cells was counted in three areas of
high-magnification fields at both superficial and deep
zones of the cartilage tissue individually by three blinded
observers. The average percentage of p-STAT3– and
MMP-13–positive cells/total cells were calculated. One
sagittal section each from six mice was evaluated in each
group. These positive cells were included superior to the
tidemark and were included for both femur and tibia.
Statistical analysis
Statistical analysis was performed using one-way (Fig. 1a, c)
or two-way (Figs. 2, 3e, 4e and 5e) analysis of variance
with Tukey’s post hoc test for multiple comparisons of
paired samples. The Mann–Whitney U test was used for
comparisons between the two groups (Fig. 6a, b). P values
less than 0.05 were considered significant. The results are
presented as mean values with 95 % confidence intervals
(95 % CIs) and were considered statistically significant at
P < 0.05.
Results
Cyclic tensile strain increased catabolic genes
Real-time PCR analysis showed that the expression of
Col2a1 in untreated control mice did not change in re-
sponse to tensile strain. ACAN in untreated control mice
increased after 3 %, 5 %, and 8 % strain; however, the ex-
pression levels were decreased after 10 % strain. More-
over, MMP3 in untreated control mice was increased
after 8 % and 10 % strain, and MMP13 was increased
after 10 % strain. ADAMTS4 in untreated control mice
was increased after 5 %, 8 %, and 10 % strain, and
ADAMTS5 was increased after 8 % and 10 % strain (Fig. 2).
These results indicate that cyclic tensile strain increased
the expression levels of ACAN and catabolic genes.
Downregulation of p21 expression decreased aggrecan
expression and increased MMP-13 expression
To analyze the function of p21 in chondrocytes in re-
sponse to mechanical stress, we compared COL2A1,
ACAN, MMPs, and ADAMTS mRNA levels in p21-
knockdown chondrocytes subjected to cyclic tensile strain.
Real-time PCR analysis showed that p21 expression
was inhibited by p21-specific siRNA transfection in all
cells subjected to tensile strain (Fig. 2). Downregulation
of p21 led to a reduction in ACAN expression after 5 %
strain in comparison with control siRNA samples, and it
increased MMP13 expression after 3 %, 5 %, and 8 %
strain (Fig. 2). However, the expression levels of ACAN
and MMP13 were unchanged in unloaded samples
(Fig. 2).
Cyclic tensile strain increased p21 mRNA expression
To evaluate the expression levels of p21, we compared
the p21 levels in chondrocytes subjected to cyclic tensile
strain. Real-time PCR analysis showed that the expres-
sion levels of p21 increased after 5 % strain (Fig. 1a).
Inhibition of STAT3 activation blocks the p21-dependent
regulation of MMP13 but not aggrecan expression
To understand the mechanism by which p21 levels affect
ACAN and MMP13 expression, we pretreated the con-
trol and p21-knockdown cells with a STAT3 inhibitor
and measured gene expression after application of 5 %
cyclic tensile strain.
Western blot analysis confirmed that the phosphoryl-
ation of STAT3 increased after p21 knockdown, but the
effect was abolished with a STAT3 inhibitor (Fig. 1b).
Real-time PCR analysis showed that STAT3 inhibitor
itself did not affect p21, ACAN, or MMP13 expression
(Fig. 1c). MMP13 expression decreased upon STAT3
inhibition after strain application, but ACAN levels were
unchanged (Fig. 1c).
p21 deficiency is susceptible to OA change in vivo
To determine the effect of p21 in vivo, we developed a
DMM model in p21-knockout mice and compared these
animals with wild-type mice 8 weeks after surgery.
Safranin O and Fast Green staining revealed that wild-
type mice showed retention of the articular surface layer;
however, loss of Safranin O staining was observed (Fig. 3c).
p21-knockout mice showed midzone excavation of the
cartilage tissue and loss of hyaline cartilage proteoglycan
staining (Fig. 3d). Wild-type or p21-knockout mice did
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not show matrix depression in the sham surgery control
group (Fig. 3a, b). According to the OARSI cartilage OA
histopathology scoring system, the average sum score was
significantly increased in the DMM wild-type mice com-
pared with sham wild-type mice. Further, the average sum
score was significantly higher in the DMM p21-knockout
mice than in the DMM wild-type mice (Fig. 3e).
p21 deficiency is susceptible to OA change through
p-STAT3 phosphorylation and MMP-13 expression
Immunohistochemistry showed that the expression le-
vels of both p-STAT3 and MMP-13 in the DMM wild-
type mice were elevated in comparison with the sham
wild-type mice (Figs. 4a, c and 5a, c). Further, the
expression levels of p-STAT3 and MMP-13 were ele-
vated in the DMM wild-type and p21-knockout mice
(Figs. 4c, d and 5c, d). The percentage of p-STAT3– and
MMP-13–positive cells were significantly increased in
the DMM p21-knockout mice compared with the DMM
wild-type mice (Figs. 4e and 5e). These results indicate
that p21 deficiency affects the phosphorylation of STAT3
and MMP-13 expression and confirm our in vitro
experiments.
p21 deficiency increased p-STAT3 phosphorylation and
F4/80 expression in the synovial tissue
Immunohistochemistry of the synovial tissue showed
that the expression levels of p-STAT3 in the DMM wild-
type mice were elevated in comparison with the sham
wild-type and p21-knockout mice (Fig. 7a–c), but the
expression levels in the DMM p21-knockout mice were
substantially elevated in comparison with the DMM
Fig. 1 Expression of p21, ACAN, and MMP-13 without and with STAT3 inhibitor. a Expression levels of p21 mRNA were quantified by real-time
PCR. Expression ratios of p21 are shown. Columns represent mean ratios with 95 % CI at 3, 5, 8, and 10 % strain/nonstrain control. b p21 and
phospho-STAT3 were analyzed by Western blotting. The results shown represent three independent experiments. c The effect of a STAT3-specific
inhibitor on p21-regulated ACAN and MMP-13 expression. Chondrocytes were transfected with p21 siRNA or nonspecific control siRNA for 12 h,
and 5 % cyclic stretch stress was introduced for 3 h in the presence of 50 μM DMSO or STAT3-specific inhibitor. Expression levels of p21, ACAN,
and MMP13 mRNAs were quantified by real-time PCR. Expression ratios of ACAN and MMP13 are shown. Columns represent mean ratios with
95 % CI against untreated control. The results shown are the average of four individual experiments. Values are normalized to GAPDH expression.
ACAN aggrecan, CI confidence interval, DMSO dimethyl sulfoxide, MMP matrix metalloproteinase, PCR polymerase chain reaction, siRNA small
interfering RNA, STAT3-I signal transducer and activator of transcription 3–specific inhibitor
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wild-type mice (Fig. 7c, d). To determine whether p21 is
implicated in the inflammatory response of the synovial
tissue in experimental OA models, we investigated F4/80
expression as an immune and inflammatory cell marker
because it is a well-known macrophage marker. Expres-
sion levels of F4/80 were similar to p-STAT expression.
The expression levels in the DMM p21-knockout mice
were elevated much higher in comparison with the DMM
wild-type mice (Fig. 7e–h). These results indicate that p21
deficiency impacts phosphorylation of STAT3 and suscep-
tibility to synovial inflammation.
Phosphorylation of STAT3 was increased in human OA
chondrocytes
We compared the phosphorylation of STAT3 in OA and
normal primary chondrocytes. Western blot analysis
showed that the expression levels of STAT3 were not
significantly changed in normal primary chondrocytes.
However, the phosphorylation of STAT3 was signifi-
cantly increased in OA chondrocytes (Fig. 6a).
Expression level of p21 was decreased in human OA
chondrocytes
To analyze the expression levels of p21 and cartilage
matrix–related genes in human chondrocytes, we com-
pared p21 mRNA levels between human normal and OA
chondrocytes. Real-time PCR showed that the p21
mRNA levels in OA chondrocytes were significantly de-
creased in comparison with the normal chondrocytes
(Fig. 6b).
Discussion
We first demonstrated that the downregulation of p21
decreased ACAN expression and increased MMP13 ex-
pression following strain application. However, the down-
regulation of p21 did not change ACAN or MMP13
expression in control cells not subjected to strain. We
concluded that p21 functioned only under mechanical
stress. We also demonstrated that the downregulation of
p21 did not increase MMP13 expression after 10 % strain.
MMP13 expression levels in untreated siRNA chondro-
cytes were increased after 10 % strain. Therefore, the
effect of p21 knockdown on MMP13 expression may be
attenuated by the upregulated MMP-13 expression.
Further, downregulation of p21 did not change ACAN
expression in response to 3 % and 10 % strain. The expres-
sion levels of p21 under 3 % and 10 % were much lower
than 5 %, and the results may be dependent on p21
expression levels.
O’Connor reported that the maximum principal stress,
though compressive under the region of contact, be-
comes tensile outside the contact patch, and localized
Fig. 2 Knockdown efficiency of p21 siRNA transfection in human normal chondrocytes in response to mechanical strain. The concentration of
p21 siRNA was 100 nM. Expression levels of p21, COL2A1, ACAN, MMP3, MMP13, ADAMTS4, and ADAMTS5 mRNAs were quantified by real-time PCR.
Values are normalized to GAPDH expression. Columns represent mean ratios with 95 % confidence intervals against untreated and nonloaded control.
The results shown are the average of four individual experiments. White columns: untreated samples, Black columns: nonspecific control siRNA
samples, and gray columns: p21 siRNA samples. ACAN aggrecan, ADAMTS a disintegrin and metalloproteinase with thrombospondin motifs, COL2A1
collagen, type II, alpha 1, MMP matrix metalloproteinase; PCR polymerase chain reaction, siRNA small interfering RNA
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Fig. 4 p21 levels influence the number of p-STAT3-positive cells in DMM mice. Cartilage tissue samples were collected from the right knee (sham
or DMM surgery) of (a) p21+/+ (sham), (b) p21−/− (sham), (c) p21+/+ (DMM), and (d) p21−/− (DMM) mice. e Percentages of pSTAT3-positive stained
cells (number of positive cells/number of total cells) with 95 % CI. The sections are stained for p-STAT3 antibody and counterstained with methyl
green. Six mice were analyzed for each of the following groups: p21+/+ sham, p21+/+ DMM, p21−/− sham, and p21−/− DMM. CI confidence interval,
DMM destabilization of the medial meniscus, p-STAT3 phosphorylated signal transducer and activator of transcription 3
Fig. 3 p21 levels influence the summed OARSI scores in DMM mice. Cartilage tissue samples were collected from the right knee (sham or DMM
surgery) of (a) p21+/+ (sham), (b) p21−/− (sham), (c) p21+/+ (DMM), and (d) p21−/− (DMM) mice. The sections are stained with Safranin O and Fast
Green. e Average summed OARSI scores with 95 % CIs from all four quadrants and eight sections. Six mice were analyzed for each group: p21+/+
sham, p21+/+ DMM, p21−/− sham, and p21−/− DMM. CI confidence interval, DMM destabilization of the medial meniscus, OARSI Osteoarthritis
Research Society International
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Fig. 5 p21 levels influence the number of MMP-13–positive cells in DMM mice. Cartilage tissue samples were collected from the right knee
(sham or DMM surgery) of (a) p21+/+ (sham), (b) p21−/− (sham), (c) p21+/+ (DMM), and (d) p21−/− (DMM) mice. e Percentages of MMP-13–positive
stained cells (number of positive cells/number of total cells) with 95 % CI. The sections are stained for MMP-13 antibody and counterstained
with methyl green. Six mice were analyzed for each group: p21+/+ sham, p21+/+ DMM, p21−/− sham, and p21−/− DMM. CI confidence interval,
DMM destabilization of the medial meniscus, MMP matrix metalloproteinase
Fig. 6 Differential expression of p21, STAT3, and p-STAT3 in normal and OA chondrocytes. a Expression of p-STAT3 and total STAT3 in normal (three
samples) and OA (three samples) primary chondrocytes analyzed by Western blotting. b Columns represent the ratios of protein expression levels
(p-STAT3/actin, STAT3/actin) determined by semiquantification of the digitally captured image. The results shown are the averages of three individual
samples. c Expression levels of p21 mRNA levels were quantified by real-time PCR. Expression ratios of p21 are shown. Columns represent mean ratios
with 95 % CIs of primary OA chondrocytes/primary normal chondrocytes. The results shown are the averages of five individual samples. Values are
normalized to GAPDH expression. CI confidence interval, OA osteoarthritis, p-STAT3 phosphorylated signal transducer and activator of transcription 3,
STAT3 signal transducer and activator of transcription 3
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tensile stress occurs in regions close to the cartilage–
bone interface as well as at the articular surface [34] . In
physiological circumstances, articular chondrocytes are
exposed to a 15 % compression load, leading to 5 %
tensile strain on chondrocytes during normal joint
movement [35]. Therefore, we used 5 % tensile strain as
normal joint loading and 10 % tensile strain as excessive
loading to investigate the relationship between mechan-
ical stress and cartilage metabolism.
To determine the mechanism underlying the changes
in ACAN and MMP13 expression, we focused on the
Janus kinase (JAK)-STAT signaling pathway. Recently, it
was reported that the JAK-STAT signaling pathway plays
a critical role in MMP13 expression in chondrocytes
[36]. Legendre et al. demonstrated that the inhibition of
the JAK-STAT pathway with a specific inhibitor dimin-
ished IL-6–induced MMP13 expression in chondrocytes
[37]. These results support our findings that the reduc-
tion of p21 increases STAT3 phosphorylation and that
inhibition of STAT3 phosphorylation diminishes p21-
regulated MMP-13 expression after mechanical stress.
However, the inhibition of STAT3 phosphorylation did
not diminish p21-regulated ACAN expression. There-
fore, p21-regulated ACAN expression does not appear to
be controlled by STAT3 signaling. Dai et al. demon-
strated that the catabolic stress induced by IL-1β or
hydrogen peroxide increased caveolin 1 and p21 expres-
sion in chondrocytes and that overexpression of caveolin
1 increased p21 expression and p38 mitogen-activated
protein kinase activation, as well as impaired the ability
of chondrocytes to induce type II collagen and ACAN
expression [38]. Those authors concluded that p21 is a
negative regulator of type II collagen and ACAN synthe-
sis. However, a direct demonstration that the p21 levels
control the expression of type II collagen and ACAN
was not performed in the aforementioned study. In con-
trast to the results of that study [35], we demonstrated
that a reduction of p21 expression decreased ACAN
expression after mechanical stress.
We established a mouse OA model and examined the
role of p21-knockout in this setting. We showed that
p21-deficient mice were susceptible to OA and this was
associated with increased STAT3 phosphorylation and
MMP-13 expression. These results supported our in
vitro experiments.
Lee et al. reported that IL-17 increased the expression
of Toll-like receptor 3 via the STAT3 pathway in
rheumatoid arthritis (RA) fibroblast-like synoviocytes
and that STAT3 phosphorylation was increased in the
synovial samples from patients with RA compared with
patients with OA [39]. However, there was no report
about STAT3 phosphorylation in comparison with OA
and normal cartilage. We first demonstrated that STAT3
phosphorylation was elevated in OA compared with
normal human cartilage and mouse OA model cartilage.
We further demonstrated that the expression levels of
p21 were decreased in human OA chondrocytes. Our
findings support the following hypothesis for the
Fig. 7 p21 levels influence p-STAT3 and F4/80 levels in DMM mice. Synovial tissue samples were collected from the right knee (sham or DMM
surgery) of (a, e) p21+/+ (sham), (b, f) p21−/− (sham), (c, g) p21+/+ (DMM), and (d, h) p21−/− (DMM) mice. The sections are stained for p-STAT3 Ab
(upper panels) and F4/80 Ab (lower panels) and counterstained with methyl green. Ab antibody, DMM destabilization of the medial meniscus,
p-STAT3 phosphorylated signal transducer and activator of transcription 3
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regulation of MMP-13 expression by p21 under physio-
logical conditions: p21 expression is decreased in the
OA joint, leading to an increase in STAT3 phosphoryl-
ation and MMP13 expression in chondrocytes.
Macrophages play a critical role in inflammation with
three major functions—antigen presentation, phagocyt-
osis, and immunomodulation—through the production
of various cytokines and growth factors [40]. Recently,
Mavers et al. demonstrated that enhanced and sustained
development of experimental inflammatory arthritis,
associated with markedly increased number of macro-
phages and severe articular destruction, was observed in
p21-knockout mice [41]. Moreover, several authors have
reported the interaction between inflammation and OA
development [42–44] . OA is a much more complex dis-
ease, with inflammatory mediators released by cartilage,
bone, and synovium [42]. We also confirmed the suscep-
tibility to synovial inflammation in p21-knockout mice
by DMM surgery. Therefore, the susceptibility to inflam-
mation in p21-knockout mice may be one of the reasons
that the p21-knockout mouse could easily develop OA
by DMM surgery.
Conclusions
The lack of p21 has catabolic effects by regulation of
ACAN and MMP-13 expression through STAT3 phos-
phorylation in the cartilage tissue. p21 may function as a
regulator of transcription factors in addition to being an
inhibitor of cell cycle progression in the cartilage tissue.
Thus, the regulation of p21 may be a therapeutic strategy
for the treatment of OA. However, p21 also plays a role as
a cell cycle regulator and as an oncogene. Therefore, fur-
ther work is required to verify that the stabilization of p21
would be a viable and safe strategy for OA treatment.
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